Abstract
We used metagenomic next-generation sequencing (mNGS) to assess the frequencies of alternative viral infections in SARS-CoV-2 RT-PCR negative persons under investigations (PUIs) (n=30) and viral co-infections in SARS-CoV-2 RT-PCR positive PUIs (n=45). mNGS identified both co-infections and alternative viral infections that were not detected by routine clinical workup.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Childrens Healthcare of Atlanta. The Yerkes NHP Genomics Core is supported in part by NIH P51 OD011132 and sequencing data was acquired on an Illumina NovaSeq6000 funded by NIH S10 OD026799. Salary support was provided by the Doris Duke Charitable Foundation Clinical Scientist Development Award 2019089 (JJW) and NIH K08 AI139348 (AP).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Emory University IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All reads (cleaned of human reads) will be submitted to the Sequence Read Archive and complete genomes will be submitted to GenBank.
